Triple
T10292310
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | human adenovirus serotype 26 |
E241391
|
entity |
| Predicate | encodesInCOVID19Vaccine |
P14248
|
FINISHED |
| Object |
SARS-CoV-2 spike glycoprotein
The SARS-CoV-2 spike glycoprotein is the viral surface protein that mediates coronavirus entry into human cells and is the primary target of neutralizing antibodies and many COVID-19 vaccines.
|
E854994
|
NE FINISHED |
Provenance (6 batches)
| Stage | Batch ID | Job type | Status |
|---|---|---|---|
| creating | batch_69d381aaafc08190af475ef58dc16aba |
elicitation | completed |
| NER | batch_69d4d2d35f048190a215493acdf1f718 |
ner | completed |
| NED1 | batch_69d71d1465e88190aaa8b295df3f9c8c |
ned_source_triple | completed |
| NED2 | batch_69d7326b14988190bff33dc01e690707 |
ned_description | completed |
| NEDg | batch_69d73180d90481908f1b4768230edd36 |
nedg | completed |
| PD | batch_69d4d1f35e548190be3b4d92d65d2d20 |
pd | completed |
Created at: April 6, 2026, 11:42 a.m.